Division of Gastroenterology, Hepatology & Nutrition, Developmental Biology, Center for Stem Cell and Organoid Medicine (CuSTOM), Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3039, USA.
Division of Gastroenterology, Hepatology & Nutrition, Developmental Biology, Center for Stem Cell and Organoid Medicine (CuSTOM), Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3039, USA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA; Institute of Research, Tokyo Medical and Dental University (TMDU), Tokyo, Japan; Communication Design Center, Advanced Medical Research Center, Yokohama City University Graduate School of Medicine, Japan.
Curr Opin Genet Dev. 2022 Aug;75:101925. doi: 10.1016/j.gde.2022.101925. Epub 2022 Jun 11.
Liver organoids are primary or pluripotent stem cell-derived three-dimensional structures that recapitulate regenerative or ontogenetic processes in vitro towards biomedical applications including disease modelling and diagnostics, drug safety and efficacy prediction, and therapeutic use. The cellular composition and structural organization of liver organoids may vary depending on the goal at hand, and the key challenge in general is to direct their development in a rational and controlled fashion for gaining targeted maturity, reproducibility, and scalability. Such endeavor begins with a detailed understanding of the biological processes in space and time behind hepatogenesis, followed by precise translation of these narrative processes through a bioengineering approach. Here, we discuss advancements in liver organoid technology through the lens of 'narrative engineering' in an attempt to synergize evolving understanding around molecular and cellular landscape governing hepatogenesis with engineering-inspired approaches for organoidgenesis.
肝脏类器官是由原代或多能干细胞衍生而来的三维结构,可在体外重现再生或个体发生过程,用于包括疾病建模和诊断、药物安全性和疗效预测以及治疗用途在内的生物医学应用。肝脏类器官的细胞组成和结构组织可能因手头的目标而异,一般来说,关键挑战是通过合理和可控的方式指导其发育,以获得靶向成熟度、可重复性和可扩展性。这种努力始于详细了解肝发生背后的时空生物学过程,然后通过生物工程方法精确转化这些叙述过程。在这里,我们通过“叙事工程”的视角讨论肝脏类器官技术的进展,试图将围绕着调控肝发生的分子和细胞景观的不断发展的理解与受工程启发的类器官发生方法相结合。